OBJECTIVE: The initial validation of a brief assessment of a diabetes-specific self-esteem dimension in adolescents with type 1 diabetes. METHODS: Youths with type 1 diabetes (n = 87) aged 10-16 years were administered the multidimensional Self-Esteem Questionnaire (SEQ) and a newly designed assessment of diabetes-specific self-esteem (DSSE). Their parents completed parallel forms. Adherence to the diabetes regimen and glycemic control were also assessed. RESULTS: In factor analysis, DSSE items formed a distinct dimension of self-esteem in addition to the SEQ dimensions. This factor uniquely contributed to differences in youths' global self-esteem. Significant associations with adherence and glycemic control suggested its concurrent validity. Agreement between youth- and parent-report DSSE forms supported inter-rater reliability. CONCLUSIONS: The findings provide preliminary support for recognizing the importance of a DSSE dimension in adolescents' adjustment to diabetes, and for the reliability and validity of the proposed assessment strategy.
OBJECTIVE: The initial validation of a brief assessment of a diabetes-specific self-esteem dimension in adolescents with type 1 diabetes. METHODS: Youths with type 1 diabetes (n = 87) aged 10-16 years were administered the multidimensional Self-Esteem Questionnaire (SEQ) and a newly designed assessment of diabetes-specific self-esteem (DSSE). Their parents completed parallel forms. Adherence to the diabetes regimen and glycemic control were also assessed. RESULTS: In factor analysis, DSSE items formed a distinct dimension of self-esteem in addition to the SEQ dimensions. This factor uniquely contributed to differences in youths' global self-esteem. Significant associations with adherence and glycemic control suggested its concurrent validity. Agreement between youth- and parent-report DSSE forms supported inter-rater reliability. CONCLUSIONS: The findings provide preliminary support for recognizing the importance of a DSSE dimension in adolescents' adjustment to diabetes, and for the reliability and validity of the proposed assessment strategy.
Authors: H B Mortensen; K J Robertson; H J Aanstoot; T Danne; R W Holl; P Hougaard; J A Atchison; F Chiarelli; D Daneman; B Dinesen; H Dorchy; P Garandeau; S Greene; H Hoey; E A Kaprio; M Kocova; P Martul; N Matsuura; E J Schoenle; O Søvik; P G Swift; R M Tsou; M Vanelli; J Aman Journal: Diabet Med Date: 1998-09 Impact factor: 4.359
Authors: A M Jacobson; S T Hauser; J I Wolfsdorf; J Houlihan; J E Milley; R D Herskowitz; D Wertlieb; E Watt Journal: J Pediatr Date: 1987-05 Impact factor: 4.406
Authors: C Nuccitelli; A Valentini; M T Caletti; C Caselli; N Mazzella; G Forlani; G Marchesini Journal: J Endocrinol Invest Date: 2017-08-12 Impact factor: 4.256
Authors: Minke M A Eilander; Maartje de Wit; Joost Rotteveel; Henk Jan Aanstoot; Willie M Bakker-van Waarde; Euphemia C A M Houdijk; Marjolein Luman; Roos Nuboer; Jaap Oosterlaan; Per Winterdijk; Frank J Snoek Journal: BMC Pediatr Date: 2015-07-15 Impact factor: 2.125